Cytomegalovirus Disease After Kidney Transplantation: Clues to Accurate Diagnosis

Transplantation Proceedings

Volumn 39, Issue 4, 2007, Pages 987-989

  Nemati, E ^a   Eizadi, M ^a   Lankarani, M Moghani ^a   Kardavani, B ^a   Khoddami Vishteh, H R ^a   Kalantar, E ^a   Lesan Pezeshki, M ^a   Khedmat, H ^a   Saadat, A R ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; SYMPTOMATOLOGY;

ADULT; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 34248538133     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.03.087     Document Type: Article

References (17)

1. Paya C.V., and Razonable R.R. Cytomegalovirus infection after solid organ transplantation. In: Bowden R.A. (Ed). Transplant infections (2003), Lippincott Williams & Wilkins, Philadelphia 298
2. Tolkoff-Rubin N.E., and Rubin R.H. Recent advances in the diagnosis and management of infection in the organ transplant recipient. Semin Nephrol 20 (2000) 148
3. Jassal S.V., Roscoe J.M., Zaltzman J.S., et al. Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation. J Am Soc Nephrol 9 (1998) 1697
4. Emery V.C. Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol 11 (2001) 83
5. Brennan D.C., Storch G.A., and Lippman B.J. Preemptive ganciclovir therapy in renal transplantation. Ann Intern Med 124 (1996) 693
6. Cransberg K., Marlies Cornelissen E.A., Davin J.C., et al. Improved outcome of pediatric kidney transplantations in the Netherlands-effect of the introduction of mycophenolate mofetil?. Pediatr Transplant 9 (2005) 104
7. Geddes C.C., Church C.C., Collidge T., et al. Management of cytomegalovirus infection by weekly surveillance after renal transplant: analysis of cost, rejection and renal function. Nephrol Dial Transplant 18 (2003) 1891
8. Yango A., Morrissey P., Zanabli A., et al. Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients. Nephrol Dial Transplant 18 (2003) 809
9. Pouteil-Noble C., Ecochard R., Landrivon G., et al. Cytomegalovirus infection--an etiological factor for rejection?. A prospective study in 242 renal transplant patients. Transplantation 55 (1993) 851
10. Keay S. CMV infection and disease in kidney and pancreas transplant recipients. Transpl Infect Dis 1 Suppl 1 (1999) 19
11. Dunn D.L., Mayoral J.L., Gillingham K.J., et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 51 (1991) 98
12. Peterson P.K., Balfour Jr. H.H., Marker S.C., et al. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 59 (1980) 283
13. Abbott K.C., Hypolite I.O., Viola R., et al. Hospitalizations for cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol 12 (2002) 402
14. Hanto D.W., Jendrisak M.D., So S.K., et al. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial. Transplantation 57 (1994) 377
15. Meier-Kriesche H.U., Ojo A., Magee J.C., et al. African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies. Transplantation 70 (2000) 375
16. Kyllonen L., Kahu J., Kyllonen L., et al. Kidney transplantation from 1119 deceased donors in Finland, 1991 to 2003: impact of donor factors. Transplant Proc 37 (2005) 3248
17. Pour-Reza-Gholi F., Labibi A., Farrokhi F., et al. Signs and symptoms of cytomegalovirus disease in kidney transplant recipients. Transplant Proc 37 (2005) 3056